Federal Computer Weekly reported today that MHS TRICARE officials and the FDA commissioner attended a recent meeting to discuss the expansion of the sharing rights to include use of MHS databases to track unexpected side effects for newly approved pharmaceuticals. It will also include investigating and tracking outbreaks of food poisonings and incidents of bioterrorism.
You need to be a member of MedTech I.Q. to add comments!
Join MedTech I.Q.